
Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …

Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …
Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …
Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …
GlaxoSmithKline has announced an alliance with JSC Binnopharm focusing on the secondary manufacture of a number of the pharmaceutical giant’s …
Novartis has forged an alliance with a Saudi Arabian manufacturer to help it expand its vaccines business in the Middle …
The World Health Organization has dropped a combination vaccine made by Sanofi-Aventis’ subsidiary Shantha Biologics from its list of prequalified …
Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

GlaxoSmithKline and Pfizer have signed a deal to supply anti-pneumococcal drugs to developing countries at steeply discounted prices. GSK will …
Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …